SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-17-042605
Filing Date
2017-02-14
Accepted
2017-02-14 12:28:57
Documents
2
Group Members
ARNOLD L. ORONSKYGILBERT H. KLIMANHARVEY B. CASHINTERWEST INVESTORS VII, LPINTERWEST MANAGEMENT PARTNERS VII, LLCINTERWEST VENTURE MANAGEMENT COPHILIP T. GIANOSW. STEPHEN HOLMES III

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d347406dsc13ga.htm SC 13G/A 151688
2 EX-99.A d347406dex99a.htm EX-99.A 11025
  Complete submission text file 0001193125-17-042605.txt   164496
Mailing Address 2710 SAND HILL ROAD, SUITE 200 MENLO PARK CA 94025
Business Address 2710 SAND HILL ROAD, SUITE 200 MENLO PARK CA 94025 6508548585
INTERWEST PARTNERS VII L P (Filed by) CIK: 0001081736 (see all company filings)

IRS No.: 943319533 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Subject) CIK: 0001582313 (see all company filings)

IRS No.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88403 | Film No.: 17605824
SIC: 2834 Pharmaceutical Preparations